Class action lawsuit brought by Eiger BioPharmaceuticals: Johnson fistula
SAN DIEGO, Nov. 08, 2022 (GLOBE NEWSWIRE) — The shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistula.com) examines whether Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), one